{"id":58658,"date":"2024-08-24T12:01:10","date_gmt":"2024-08-24T12:01:10","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/08\/24\/capital-and-business-alliance-formed-between-medirom-mother-labs-and-nfes-technologies\/"},"modified":"2024-08-24T12:01:10","modified_gmt":"2024-08-24T12:01:10","slug":"capital-and-business-alliance-formed-between-medirom-mother-labs-and-nfes-technologies","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/capital-and-business-alliance-formed-between-medirom-mother-labs-and-nfes-technologies\/","title":{"rendered":"Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies"},"content":{"rendered":"
\n

NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen<\/em><\/p>\n

\"image1.png\"<\/p>\n

TOKYO, Aug. 23, 2024 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Koji Eguchi; listed on Nasdaq, NASDAQ: MRM; hereinafter \u201cMEDIROM\u201d) announces that its subsidiary MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; CEO: Yoshio Uekusa; hereinafter \u201cMOTHER Labs\u201d), has formed a capital and business alliance with NFES Technologies Inc. (Headquarters: Matsue City, Shimane Prefecture; CEO: Keita Adachi; hereinafter \u201cNFES Group\u201d), a subsidiary of NFES Inc. (Headquarters: Matsue City, Shimane Prefecture; CEO: Keita Adachi).<\/p>\n

As part of this alliance, NFES Group has agreed to participate as the lead investor in MOTHER Labs\u2019 Series A financing round, which values MOTHER Labs at 9 billion yen on a pre-money basis. The Series A shares will be issued to NFES Group as a third-party allotment.<\/p>\n

◾️Background of the Capital and Business Alliance<\/strong>
The NFES Group is committed to creating a world where individuals can passionately pursue what they love. They resonate with MOTHER Labs\u2019 dedication to global challenges as a Japanese company and the concept behind the MOTHER Bracelet, a recharge-free smart tracker designed to monitor people\u2019s health. This shared vision led to the capital and business alliance, with the aim of collaborating with MOTHER Labs to promote the MOTHER Bracelet and support the health of people worldwide.<\/p>\n

◾️Future Initiatives<\/strong>
We have concluded a distributorship agreement for MOTHER Bracelet, the recharge-free smart tracker developed by the MEDIROM group, and MOTHER Gateway, MEDIROM\u2019s telecommunication device which exclusively enables data generated by MOTHER Bracelet to be sent to our proprietarily developed remote monitoring system, and will introduce these products to companies in the nursing care, transportation, and manufacturing industries and promote their introduction through collaborations with financial institutions and sales partners allied with NFES Group.<\/p>\n

In addition, MOTHER Labs will also collaborate with Hyakkaten.com (a regional department store e-commerce mall operated by NFES Group) to conduct general sales through department stores and e-commerce sites nationwide.<\/p>\n

With NFES Group participating as the lead investor in this Series A round, we anticipate attracting additional investors, allowing us to secure the necessary funds for MOTHER Labs\u2019 business expansion and facilitating the company\u2019s further business development.<\/p>\n

◾️Sales Structure<\/strong>
The NFES Group has established a new company, NFES Technologies Inc., specializing in sales of MOTHER Bracelet and plans to expand sales both domestically and internationally as the designated main distributor of MOTHER Bracelet products.<\/p>\n

\"image3.jpg\"<\/p>\n

Forward-Looking Statements Regarding MEDIROM and MOTHER Labs<\/strong><\/p>\n

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM\u2019s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cdesign,\u201d \u201ctarget,\u201d \u201caim,\u201d \u201chope,\u201d \u201cexpect,\u201d \u201ccould,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cbelieve,\u201d \u201ccontinue,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cpotential,\u201d \u201cgoal,\u201d or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM\u2019s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM\u2019s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM\u2019s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM\u2019s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM\u2019s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:<\/p>\n